Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
Laura Cicconi(San Antonio College), Francesco Lo‐Coco(Fondazione Santa Lucia), Chiara Frairia(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Christian Thiede(University Hospital Carl Gustav Carus), Giuseppe Avvisati(Università Campus Bio-Medico), Francesca Paoloni(Fondazione Gimema Onlus), Claudio Fozza(University of Sassari), Nicola Di Renzo(Presidio Ospedaliero), Arnold Ganser(Medizinische Hochschule Hannover), Peter Brossart(University of Bonn), Paola Fazi(Fondazione Gimema Onlus), Gerhard Ehninger(University Hospital Carl Gustav Carus), Ombretta Annibali(Link Campus University), Mohammed Wattad(San Antonio College), Roberto Cairoli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Fabio Efficace(Fondazione Gimema Onlus), Helmut R. Salih(German Cancer Research Center), Christoph Röllig(University Hospital Carl Gustav Carus), Erika Borlenghi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Lorella Melillo(San Antonio College), Giorgio La Nasa(University of Cagliari), Felicetto Ferrara(San Antonio College), Michael Lübbert(University of Freiburg), Richard F. Schlenk(German Cancer Research Center), Konstanze Döhner(University Hospital Ulm), Mariadomenica Divona(San Antonio College), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Bernd Hertenstein(San Antonio College), Hartmut Link(Medizinische Hochschule Hannover), Mathias Hänel(Klinikum Chemnitz), Maria Teresa Voso(University of Rome Tor Vergata), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Francesco Albano(University of Bari Aldo Moro), Alfonso Maria D’Arco(Fondazione Intergruppo Italiano Linfomi Onlus), Marco Vignetti(Fondazione Gimema Onlus), Uwe Platzbecker(National Center for Tumor Diseases), Sergio Amadori(Polyclinic Medical Center), Christian Brandts(Goethe University Frankfurt), Walter Fiedler(Universität Hamburg), Hartmut Döhner(University Hospital Ulm), Massimo Breccia(Policlinico Umberto I), Francesco Fabbiano(San Antonio College), Franco Mandelli(San Antonio College), Norbert Schmitz(University Hospital Münster), Eros Di Bona(San Antonio College), Marco Sborgia(Radboud University Nijmegen)
Cited by 72
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k